ClinicalTrials.Veeva

Menu

Effect of Blood Pressure on rSO2 in Carotid Endarterectomy (CEA)

G

G.J. de Borst

Status

Unknown

Conditions

Intra-operative Hypotension
Carotid Stenosis

Treatments

Drug: Administration of phenylephrine
Drug: Administration of ephedrine

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Carotid endarterectomy (CEA) is the recommended treatment for symptomatic high degree stenosis of the internal carotid artery (ICA). ICA obstruction is often associated with an impaired cerebral autoregulation, implicating that cerebral perfusion pressure becomes dependent on systemic blood pressure. Therefore, to maintain cerebral perfusion pressure in this type of patients intraoperative hypotension needs to be avoided. Different short-acting agents such as phenylephrine, (a drug with vasoconstrictive properties), or ephedrine (a drug with vasoconstrictive properties combined with an increase in heart rate) can be used to correct intra-operative hypotension. In healthy subjects these agents affect the cerebral perfusion differently despite an identical effect on the systemic blood pressure. Cerebral perfusion decreases after phenylephrine administration while it is preserved after the use of ephedrine. The optimal agent for correcting hypotension in CEA patients, and thus in a situation of an impaired cerebral autoregulation, is unknown.

Therefore, the investigators propose to perform a prospective study observing the effect of phenylephrine and ephedrine on cerebral perfusion to make a recommendation regarding the use of either phenylephrine or ephedrine during CEA.

Enrollment

40 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. All patients undergoing CEA in the University Medical Centre Utrecht and having an appropriate temporal bone window for reliable perioperative TCD monitoring could be included.
  2. All patients must have given written informed consent.

Exclusion criteria

  1. Not having a temporal bone window appropriate for TCD measurement
  2. Not willing to give informed consent.
  3. If the effect on BP of the given agents is insufficient (if relative hypotension persists five minutes after administration).

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

40 participants in 2 patient groups

Ephedrine
Active Comparator group
Treatment:
Drug: Administration of ephedrine
Phenylephrine
Active Comparator group
Treatment:
Drug: Administration of phenylephrine

Trial contacts and locations

1

Loading...

Central trial contact

Gert Jan de Borst, MD, PhD; Claire Pennekamp, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems